Neuralgic Amyotrophy Associated with Antibiotic Therapy

Finstad, Kody; Guajardo, Jesus R.; Scoville, Caryn

doi:10.1345/aph.1l185

Cited by 7 publications

(4 citation statements)

References 13 publications

(15 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It was considered that norvancomycin caused adverse reactions of peripheral neuropathy. Korver Gretchen reported a case of neuropathic muscle atrophy with bilateral shoulder pain and weakened upper limb function after 2 days of treatment with vancomycin, tobramycin and piperacillin tazobactam in a patient with cystic fibrosis [18]. Although it is impossible to determine which drug caused it, vancomycin is likely to be the only culprit.…”

Section: Discussionmentioning

confidence: 99%

The First Case of Vancomycin Induced Neurotoxicity and Literature Review

Wan

2024

J Clin Stud Rev Rep

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

The First Case of Vancomycin Induced Neurotoxicity and Literature Review

Wan

2024

J Clin Stud Rev Rep

View full text Add to dashboard Cite

show abstract

“…Ultimately, the recovery largely depends on rehabilitation, which can be initiated immediately after the painful phase. It’s worth noting that some cases of neuralgic amyotrophy have also been reported following antibiotic treatments ( 5 ). Combination therapy with BRAF/MEK inhibitors has significantly improved the prognosis of patients with BRAF-mutant metastatic melanoma.…”

Section: Discussionmentioning

confidence: 99%

Case report: Parsonage-turner syndrome in a melanoma patient treated by BRAF/MEK inhibitors after immune checkpoint inhibitors

Bonnefin,

Duval,

Rouanet

et al. 2023

Front. Oncol.

View full text Add to dashboard Cite

IntroductionCombination molecular BRAF/MEK inhibitors targeted therapy has been shown to improve overall survival in patients with BRAF V600 mutated unresectable or metastatic melanoma. Most patients treated with BRAF/MEK inhibitors will experience adverse events but neurological adverse events (nAEs) remain rare.Case reportA 42-year-old woman diagnosed with metastatic melanoma presented with an intense pain in the left shoulder 7 days after the beginning of encorafenib/binimetinib after immune checkpoint inhibitors (ICI) combination. No other triggering factors were identified. Electromyogram performed one month after the pain onset revealed a left brachial plexopathy suggestive of a Parsonage-Turner syndrome. The weakness slowly improved with intensive rehabilitation and targeted therapies were continued.ConclusionWe report the first case of Parsonage-Turner syndrome in a melanoma patient treated with encorafenib/binimetinib following checkpoint inhibitors combination.We cannot rule out the implication of ICI in the development of this syndrome but the rapid onset of the symptoms after the beginning of targeted therapies makes their involvment more likely.Given the increased use of BRAF/MEK inhibitors in managing of stage III and IV melanoma, as well as the development in stage II, clinicians should be aware of this potential side effect.

show abstract

“…reported one case of INA in 22 years male with cystic fibrosis after vancomycin administration. [ 6 ] Al Masri et al . reported a case of tacrolimus associated BN in pediatric renal transplant recipient.…”

Section: Discussionmentioning

confidence: 99%

Idiopathic brachial neuritis in a child: A case report and review of the literature

et al. 2014

View full text Add to dashboard Cite

Brachial neuritis is a rare disease in children, affecting mainly the lower motor neurons of the brachial plexus and/or individual nerves or nerve branches. We report a case of idiopathic brachial plexus neuritis in a 2½-year-old female child admitted with acute respiratory distress and given antibiotic therapy following which she developed weakness of the left hand. She was diagnosed as a case of idiopathic brachial plexus neuritis and was given supportive care. Although, the association with antibiotic therapy in this case could be incidental, indeed it is intriguing and requires further studies.

show abstract

Neuralgic Amyotrophy Associated with Antibiotic Therapy

Abstract: Clinicians should be aware of this adverse reaction when facing similar complex neurologic symptoms in patients who are receiving the antibiotic treatment described here, especially vancomycin.

Cited by 7 publications

References 13 publications

The First Case of Vancomycin Induced Neurotoxicity and Literature Review

The First Case of Vancomycin Induced Neurotoxicity and Literature Review

Case report: Parsonage-turner syndrome in a melanoma patient treated by BRAF/MEK inhibitors after immune checkpoint inhibitors

Idiopathic brachial neuritis in a child: A case report and review of the literature

Contact Info

Product

Resources

About